US Patent 11098289 Uricase sequences and methods of treatment
Patent 11098289 was granted and assigned to MedImmune, LLC on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+144 characters)
Article
Patent abstract
Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Andrew C. Nyborg0
Manuel Baca0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110982890
Date of Patent
August 24, 2021
0Patent Application Number
201605130
Date Filed
May 13, 2016
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11098289 Uricase sequences and methods of treatment
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11098289
Date of patent
August 24, 2021
Patent application number
20160513
Date Filed
May 13, 2016
Find more entities like US Patent 11098289 Uricase sequences and methods of treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.